The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 18, 2023

Filed:

Dec. 19, 2018
Applicants:

Industry Foundation of Chonnam National University, Gwangju, KR;

Chonnam National University Hospital, Gwangju, KR;

Inventors:

Myung Ho Jeong, Gwangju, KR;

Dae Sung Park, Gwangju, KR;

In-Ho Bae, Gwangju, KR;

Kyung Seob Lim, Gwangju, KR;

Jae Won Shim, Gwangju, KR;

So Youn Lee, Gwangju, KR;

Eun Jae Jang, Gwangju, KR;

Doo Sun Sim, Gwangju, KR;

In Soo Kim, Gwangju, KR;

Jun Kyu Park, Gwangju, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61L 31/08 (2006.01); A61L 24/02 (2006.01); A61F 2/00 (2006.01); A61F 2/82 (2013.01); A61K 31/436 (2006.01); B23K 26/352 (2014.01); C23C 16/30 (2006.01); B23K 26/0622 (2014.01);
U.S. Cl.
CPC ...
A61L 31/088 (2013.01); A61F 2/0077 (2013.01); A61F 2/82 (2013.01); A61K 31/436 (2013.01); B23K 26/0624 (2015.10); B23K 26/352 (2015.10); C23C 16/308 (2013.01); A61F 2002/0086 (2013.01); A61F 2240/002 (2013.01); A61F 2250/0068 (2013.01); A61L 2300/416 (2013.01); A61L 2420/02 (2013.01); A61L 2420/08 (2013.01);
Abstract

A tacrolimus drug-eluting stent manufacturing method according to the present invention enables a tacrolimus drug to be strongly and stably bound onto a stent, while also not necessarily involving a separate step of introducing a surface-binding functional group for the binding of a drug onto a stent and a step of introducing, into the drug, a functional group capable of binding to the surface-binding functional group, and a tacrolimus drug-eluting stent manufactured by the manufacturing method has a greater total drug elution amount and has a more excellent delayed drug-elution property.


Find Patent Forward Citations

Loading…